With 23andMe in ‘financial distress,’ California official issues alert to customers
By Jason Green,
The Mercury News
| 03. 24. 2025
With genetic testing company 23andMe facing an increasingly uncertain future, California Attorney General Rob Bonta on Friday reminded customers they have the right to tell the firm to permanently delete their data.
The South San Francisco-based company has publicly reported it is in “financial distress” and stated in recent securities filings that there is substantial doubt about its ability to keep going, the California Attorney General’s Office said in a news release.
The “trove of sensitive consumer data” amassed by 23andMe is subject to deletion under both the Genetic Information Privacy Act and the California Consumer Protection Act, according to the office.
“California has robust privacy laws that allow consumers to take control and request that a company delete their genetic data,” Bonta said in a statement. “Given 23andMe’s reported financial distress, I remind Californians to consider invoking their rights and directing 23andMe to delete their data and destroy any samples of genetic material held by the company.”
Customers can delete their 23andMe account and personal information by taking the following steps:
- Log into your 23andMe account on the...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...
